Year
DEALS // DEV.
Country
Therapeutic Area
Study Phase
Deal Type
Product Type
Dosage Form
Lead Product
Target
Lead Product(s) : Aztreonam
Therapeutic Area : Infections and Infectious Diseases
Study Phase : Approved
Sponsor : Advanz Pharma
Deal Size : Undisclosed
Deal Type : Acquisition
Details : ADVANZ strengthens its specialty and hospital business by gaining an anti-infective portfolio from Sanofi made up of eight anti-infectives including Azactam (aztreonam), Cefotax, Claforan, Oroken, Rulid, Suprax, Wintriaxone and Colistimethate Sodique pro...
Brand Name : Azactam
Molecule Type : Small molecule
Upfront Cash : Undisclosed
October 03, 2022
Lead Product(s) : Aztreonam
Therapeutic Area : Infections and Infectious Diseases
Highest Development Status : Approved
Sponsor : Advanz Pharma
Deal Size : Undisclosed
Deal Type : Acquisition
Lead Product(s) : Aztreonam,Avibactam,Metronidazole
Therapeutic Area : Infections and Infectious Diseases
Study Phase : Approved
Sponsor : Not Applicable
Deal Size : Not Applicable
Deal Type : Not Applicable
European Commission Approves Pfizer’s EMBLAVEO® for Resistant Infections
Details : Emblaveo (aztreonam-avibactam), a beta-lactamase inhibitor, is FDA approved for treating adult patients with complicated intra-abdominal infections, HAP, and cUTIs, including pyelonephritis.
Brand Name : Emblaveo
Molecule Type : Small molecule
Upfront Cash : Not Applicable
April 22, 2024
Lead Product(s) : Aztreonam,Avibactam,Metronidazole
Therapeutic Area : Infections and Infectious Diseases
Highest Development Status : Approved
Sponsor : Not Applicable
Deal Size : Not Applicable
Deal Type : Not Applicable
Lead Product(s) : Aztreonam,Avibactam,Metronidazole
Therapeutic Area : Infections and Infectious Diseases
Study Phase : Phase III
Sponsor : Not Applicable
Deal Size : Not Applicable
Deal Type : Not Applicable
Details : ATM-AVI (aztreonam-avibactam) is an investigational treatment for infections caused by Gram-negative bacteria with limited treatment options. It combines aztreonam, a monobactam β-lactam, with avibactam, a recent broad-spectrum β-lactamase inhibitor.
Brand Name : ATM-AVI
Molecule Type : Small molecule
Upfront Cash : Not Applicable
June 01, 2023
Lead Product(s) : Aztreonam,Avibactam,Metronidazole
Therapeutic Area : Infections and Infectious Diseases
Highest Development Status : Phase III
Sponsor : Not Applicable
Deal Size : Not Applicable
Deal Type : Not Applicable
LOOKING FOR A SUPPLIER?